About Us

Cataract & Refractive Surgery Today is uniquely positioned within the ophthalmic marketplace to serve both physician and industry needs.

Targeted content for a clearly defined audience.
Our audience is 8,752 cataract and refractive surgeons, period! We cater to those surgeons who are looking for a comprehensive editorial package that suits their specific interests. Our how-to format promotes continuing education with topics such as the latest surgical approaches and techniques, complications management and avoidance pearls, practice management and business advice, and the latest technological advances. CRSToday picks up where other publications leave off with in-depth reporting, multiple contributors, and a balanced presentation.

A forum for the latest surgical developments.
CRSToday is not only concerned with what's now, but also what's next. Our readers, more so than other subspecialists, are looking for the latest in product releases and technological developments, both in the US and internationally. Surgeons investing in a technology want to know what its long-term benefits will be, and so we look beyond clinical approvals into potential future applications.

The informative connection between industry and surgeons.
CRSToday is a targeted, cost-effective vehicle through which industry can aim marketing/advertising messages to cataract and refractive surgeons. In a sea of broadly focused ophthalmology publications, CRSToday's content is appropriately tailored to our target audience. Our readers will never need to flip through articles written for glaucoma, retinal, and other subspecialists.

People are talking.
Each of our 11 yearly issues strives to capture the quality and excitement of the information offered at meetings such as ASCRS. We have even visited courtrooms to bring our readers the most thorough, timely information on legislative issues that impact their practices. Judging from the responses we've received, surgeons like what they're seeing. Read a few of the notes to the right and see what physicians and industry professionals are saying about CRSToday.